Maneesh Goyal
Angel investor in Irvine
Irvine, California
Maneesh Goyal, Angel investor in Irvine is an active investor based in Irvine, California. This profile covers what Maneesh Goyal backs, at which stage, and how founders can reach out in 2026.
Mr. Maneesh Goyal serves as Chief Operating Officer at Mayo Clinic Platform. Mr. Goyal serves as Chief Operating Officer, Mayo Clinic Platform at Mayo Clinic. He served as a Board Member at Lucem Health. He serves as a Board Member and Chairman of the Audit Committee at Medically Home. Mr. Goyal served as a General Partner at MergerTech. He served as an Advisor at Fika Ventures. He leads M&A, strategic partnerships and alliances, and the CaféWell Connect partner program. He brings a cross-disciplinary background in finance, investing, product development, and engineering. Before joining Welltok, he was a Managing Director with Miramar Venture Partners, a leading early-stage investor focusing on the information technology space. With Miramar, he led investments and was an advisor and board member for several health and consumer Internet companies. Before entering the venture world, he was an early employee with Broadcom, a Fortune 500 Company, leading product development and engineering efforts in more than a dozen communications technology solutions. He earned a bachelor's degree in biomedical engineering from Worcester Polytechnic Institute, a master's in electrical engineering from the University of Southern California, and an MBA from the Anderson School of Management at the University of California, Los Angeles.
- Investor type
- Angel
- Stages
- Early Stage VenturePre SeedSeedLate Stage Venture
- Invests in
- Healthcare & BiotechArtificial IntelligenceFintechFoodTech & Agriculture
- Location
- Irvine, California
- Typical check
- $375K
- Past investments
- 12
Notable investments
Medically Home
GenomeraMassive Health (Acquired by Aliph/Jawbone)
Massive Health
Welltok, Inc.RealPracticeLucirixResyTribogenicspymetricsMiramar Venture PartnersLucem HealthHow to reach Maneesh Goyal
Angels and operators like Maneesh Goyal reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Maneesh Goyal." Round Funded investor database, updated September 28, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/maneesh-goyal-153148-7
Frequently Asked Questions
What does Maneesh Goyal invest in?
Maneesh Goyal invests in Healthcare & Biotech, Artificial Intelligence, Fintech and FoodTech & Agriculture, typically at Early Stage Venture, Pre Seed, Seed and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Maneesh Goyal invest at?
Maneesh Goyal typically invests at Early Stage Venture, Pre Seed, Seed and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Maneesh Goyal's typical check size?
Maneesh Goyal typically writes checks around $375K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.